HOME >> MEDICINE >> NEWS
Examination of possible conflicts of interest to influence look at suspected adverse drug reactions

A review of the published literature and of internal company documents from the manufacturer of cerivastatin, a cholesterol lowering drug removed from the market in 2001, suggests that information about serious adverse effects of this medication was known to the company within months after this drug was launched, and that company analyses showing substantially increased risk of rhabdomyolysis were apparently not published or disseminated to physicians and patients. The article, released early online today because of its relevance to current events, is to be published in the December 1 issue of JAMA.

According to background information in the article, "For medicines that are effective, prompt approval provides rapid access to the health benefits of new drugs. At the same time, U.S. patients are increasingly the first to receive new medications, some of which are subsequently discovered to have serious adverse effects. As a result, the challenge of early detection is increasingly borne by the U.S. postmarketing systems."

Bruce M. Psaty, M.D., Ph.D., from the University of Washington, Seattle, and colleagues conducted a search of the published medical literature and reviewed internal company documents that have become part of the public record during a trial in Nueces County, Texas. The information gathered was used to review the association between the use of cerivastatin sodium (a statin drug removed from the market in 2001) and the risk of rhabdomyolysis (a disorder involving damage to muscle tissue) to illustrate the operation and limitations of the current U.S. postmarketing safety-surveillance system.

"Soon after marketing [of cerivastatin], spontaneous reports identified cases of rhabdomyolysis, an uncommon condition in which the breakdown of skeletal muscle cell causes pain, weakness, and in some cases, renal failure and death," the authors report. "Many but not all of them occurred in cerivastatin users who also took gemfibrozil (a
'"/>

Contact: Pam Sowers
206-543-3620
JAMA and Archives Journals
22-Nov-2004


Page: 1 2 3

Related medicine news :

1. For Breast Self-Examination, Once A Month Is Quite Enough
2. New studies suggest airborne SARS transmission is possible
3. Research suggests possible blood test for multiple sclerosis
4. Induction at 32 weeks possible action for expectant moms with premature membrane rupture
5. Sequential MDCT sufficient for determining possible risk of coronary artery disease
6. Viral DNA sequence a possible trigger for breast cancer
7. Mice with depression-like behaviors reveal possible source of human depression
8. New test possible aid to overcoming barriers to colon cancer screening
9. Supporters of NIH policy see publishers gambit as possible diversion
10. Two days of post-surgical pain relief now possible with just one shot
11. Technology points to possible targets for epilepsy and Alzheimers drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... ... both directly with persons with autism and other developmental disabilities, as well as ... intervention, parent education, adolescents with autism, school consultation, and staff development. She joined ...
(Date:8/28/2020)... ... 2020 , ... Ernst & Young LLP (EY US) today ... The Year® 2020 Florida Award finalist. Now in its 34th year, the Entrepreneur ... and prosperity as they build and sustain successful businesses that transform our world. ...
(Date:8/28/2020)... ... August 28, 2020 , ... With in-person gluten-free events being ... helping the specialty-diet community connect with great, gluten-free brands. At the Online ... chat with brands & watch over 50 educational classes... all online from the ...
(Date:8/28/2020)... LOS ANGELES (PRWEB) , ... August 28, 2020 ... ... reports on international observations that strongly suggest that obese individuals are at an ... obese people are any more likely to catch COVID-19; however, because the same ...
(Date:8/27/2020)... MORRISTOWN, N.J. (PRWEB) , ... August 27, 2020 ... ... has continued to partner with Evolution Labs to provide their students with Suite360:Mental ... issues related to Mental Health, Substance Abuse and Child Trafficking Prevention. , Florida ...
Breaking Medicine News(10 mins):
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... Dr. ... reproductive and endoscopic surgeon and serves as a clinical professor in the Department of ... of the American Laparoscopy Society & Pacific Coast Reproductive Society and is a Clinical ...
(Date:8/27/2020)... ... , ... The flu season is right round the corner and the risk of getting caught ... measures before it begins to harbor its effects on us. Already with the sudden outbreak ... impact on our lives. Hence it has become even more relevant to keep oneself immune ...
(Date:8/27/2020)... ... August 27, 2020 , ... The GHT Companies ... its fundraising initiative for Feeding San Diego with a press conference at ... Companies presents the final check of $5,000.00+ representing an overall donation result exceeding $30,000 ...
Breaking Medicine Technology:
Cached News: